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Abstract 
 
Objectives: 
Motor coordination problems are frequent in children with attention deficit/hyperactivity disorder 
(ADHD). We performed the first genome-wide association study to identify genes contributing to motor 
coordination problems, hypothesizing that the presence of such problems in children with ADHD may 
identify a sample of reduced genetic heterogeneity. 
Methods: 
Children with ADHD from the International Multicentre ADHD Genetic study (IMAGE) study were 
evaluated with the Parental Account of Children’s Symptoms. Genetic association testing was performed 
in PLINK on 890 probands with genome-wide genotyping data. Bioinformatics enrichment-analysis was 
performed on highly ranked findings. Further characterization of the findings was conducted in 313 Dutch 
IMAGE children using the Developmental Coordination Disorder Questionnaire (DCD-Q).  
Results: 
Although none of the findings reached genome-wide significance, bioinformatics analysis of the top-
ranked findings revealed enrichment of genes involved in motor neuropathy and Amyotrophic Lateral 
Sclerosis (ALS). Genes involved in neurite outgrowth and basic muscle function were also enriched. 
Among the highest ranked genes were MAP2K5, involved in Restless Legs Syndrome, and CHD6, 
causing motor coordination problems in mice. Further characterization of the top-ranked findings using 
DCD-Q subscales found nominal association for 15 SNPs.  
Conclusions: 
Our findings provide clues about the etiology of motor coordination problems, but replication studies in 
independent samples are necessary.  
 
Key words: motor coordination problems, ADHD, genome-wide association study (GWAS), 
bioinformatics analysis, neurite outgrowth, skeletal muscle function  
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Introduction 
 
With a prevalence of 5% at school age, motor coordination problems are common in children and are 
usually referred to as Developmental Coordination Disorder (DCD) (American Psychiatric Association 
2000; Kirby and Sugden 2007; Missiuna et al. 2008; Lingam et al. 2009). DCD is a heterogeneous 
condition. Motor milestones such as crawling and walking may be delayed, while some children show 
marked hypotonia and/or clumsiness (Green et al. 2008; Wilson and Larkin 2008). The motor problems 
lead to difficulties in everyday living and often have an effect on academic performance, sports, play and 
self-esteem (Cummins et al. 2005; Polatajko and Cantin 2005; Miyahara and Piek 2006; Piek et al. 2008). 
Delay of maturation in the brain as well as functional deviations in basal ganglia, parietal lobe and 
cerebellum have been suggested as the dominant source of neuropathology in motor coordination 
problems (Zwicker et al. 2009). DCD is considered a multifactorial disorder in which genetic factors and 
environmental factors such as perinatal adversity play a role (Pearsall-Jones et al. 2009). Only one study 
has formally examined the heritability of DCD in a population-based twin study (Martin et al. 2006) and 
estimated it to be 0.69. In our study of sib pairs, we found a familial component (comprising genetic and 
environmental effects) of 0.47 (Fliers et al. 2009). The genetic component appears polygenic with many 
genes, all of small effect, thought to cause the disorder together or in interaction with unfavorable 
environmental circumstances.  
Children with motor coordination problems usually have problems in other areas of development as well, 
including dyslexia, autistic spectrum disorders and Attention Deficit/Hyperactivity Disorder (ADHD). 
The other way around, we and others found that of children with ADHD, 30 to 50% also suffer from 
motor coordination problems (Gillberg et al. 2004; Fliers et al. 2008). The combination of ADHD and 
motor coordination problems has previously been named Deficits of Attention and Motor Perception, 
DAMP (Kadesjo and Gillberg 1998; Gillberg et al. 2004). At present, we can only speculate about the 
underlying neurobiological mechanisms for this comorbidity, but a dopamine-induced imbalance of basal 
ganglia neurocircuits may play a role (Arnsten 2006).  
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Previous work on the familiality of these two disorders identified a possible shared etiological 
background. In the Dutch sample of the International Multicenter ADHD Genetics (IMAGE) study, we 
found that ADHD and motor coordination problems have a common basis that may be due to genetic 
factors and/or shared environmental factors. The familial correlation between motor performance 
measures and ADHD was found to be 0.38 (Fliers et al. 2009). These results are in line with a twin study 
of the shared background of ADHD and DCD, in which a shared heritability of between 29% and 51% 
was observed (Martin et al. 2006).  
Despite a considerable familial component involved in motor coordination problems of 0.47 as measured 
by the Developmental Coordination Disorder Questionnaire (DCD-Q) in sib pairs (Fliers et al. 2009), 
little is known about the specific genetic factors involved. Since more knowledge about genetic factors 
involved in motor coordination problems may help to better understand their etiology, we set out to 
perform a hypothesis-generating genome-wide association study (GWAS) to search for DNA variation 
contributing to the condition. GWA studies are a powerful tool to identify genetic factors of limited effect 
size (McCarthy et al. 2008). In GWAS, hundreds of thousands of single –nucleotide polymorphisms 
(SNPs) are tested for association with a disease. This method has revolutionized the search for genetic 
influence on complex traits such as ADHD, in which both genetic and environmental factors work 
together. GWAS build on the mapping of SNPs, that are transmitted in blocks over the generations. This 
way one particular SNP is able to capture the majority of SNP variation in a block. Recent technology 
now allows reliable genotyping of up to 1 million SNPs in a single person. We hypothesized that studying 
motor coordination problems in a sample of ADHD-affected children might reduce the phenotypic and 
genetic heterogeneity of motor problems. In the current study, phenotypic information on motor problems 
and genome-wide genotyping data were available for 890 children from the IMAGE study. We performed 
bioinformatics analysis on the highest ranked findings to test for enrichment of gene functional groups. 
Findings were further characterized in more detail using a second phenotyping instrument in the Dutch 
IMAGE subsample.  
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Methods 
 
Participants 
Children with ADHD and their siblings were recruited for the IMAGE study that aims at identifying 
genes that increase the risk for ADHD using QTL linkage and association strategies (Brookes et al. 2006; 
Kuntsi et al. 2006). Families were identified through ADHD probands aged 5–17 years attending 
outpatient clinics at the data collection sites in Europe (Belgium, Germany, Ireland, The Netherlands, 
Spain, Switzerland, and the United Kingdom) and Israel. Families of European Caucasian ancestry were 
recruited based on having one child with ICD-10 or DSM-IV ADHD and at least one other child who 
would provide DNA and quantitative trait data. In addition, both parents had to be available for DNA-
sampling.ADHD Diagnosis was based on DSM-IV criteria using both parent and teachers questionnaires 
and  standardized interviewing. Instruments used were the SDQ, Conners P and T long version, and 
Parental Account of Children’s Symptoms (PACS) interview  
Exclusion criteria applying to all children included an IQ <70, known genetic syndromes (Down, Turner, 
Fragile X), brain disorders, for example periventricular hemorrhage, cerebral palsy and epilepsy, autism, 
seizures  current or in the past, as well as all disorders with symptoms potentially mimicking ADHD. 
Additional details about the clinical characteristics and the diagnostic process of this sample have been 
described earlier (Brookes et al. 2006; Kuntsi et al. 2006; Chen et al. 2008; Christiansen et al. 2008; Zhou 
et al. 2008; Mulligan et al. 2009). Briefly, co-occurring disorders were the following:. Mood disorder: 
23.5% (n 69), Anxiety disorder: 52.7% (n 155),  ODD: 56.5% (n 166), Conduct disorder : 18.7% (n 55). 
Mean IQ was 98. Children with and without motor problems did not differ according to age, gender and 
also severity of ADHD symptoms (Fliers, 2008). In case of the use of medication parents were asked to 
report on their children’s behavior without medication. 
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Motor measures 
Parental Account of Children’s Symptoms (PACS) interview 
The PACS, a semi-structured, standardized, investigator-based interview (Taylor et al. 1986), was 
administered to all parents. In order to ensure cross-site consistency in measurement and coding of the 
PACS all interviewers from each site attended a 5 day PACS training course in the UK. The chief 
investigator at each site attended an annual inter-rater reliability exercise.  A mean Kappa coefficient  
across all sites was 0.88 indicating a substantial level of interrater agreement. The PACS covers DSM-IV 
symptoms of ADHD, conduct disorder, oppositional defiant disorder, anxiety, mood, and other 
internalizing disorders. Moreover, questions regarding motor development are included. For this specific 
study, we analysed the question “does your child have motor coordination problems”, with 3 possible 
answers: “no”, “maybe”, or “yes definitely” as the primary phenotype for genetic analysis.  
 
Developmental Coordination Disorder Questionnaire (DCD-Q) 
In the Dutch participants of IMAGE, we collected additional data on motor performance by means of the 
DCD-Q, completed by parents (Fliers et al. 2008). The DCD-Q identifies children with motor coordination 
problems in daily life and is widely used in international studies (Wilson et al. 2000, 2009; Loh et al. 2009) 
The Dutch DCD-Q has been validated (Schoemaker et al. 2006). The internal consistency of the 
questionnaire is high (alpha = 0.88). The DCD-Q contains 17 items that are rated on a 5-point scale (1 = 
not at all like this child; 5 = extremely like this child) and 4 subscales: motor control in motion, fine motor 
control/handwriting, gross motor control/planning and general coordination. In this study DCD-Q scores 
were tested as secondary phenotypes in the genetic analysis of candidate SNPs. The scores were used on a 
continuum. We tested five traits: the total score on the DCD-Q (range from 17 to 85), and the four subscale 
scores.  
 
Genetic Analysis 
Verwijderd: Interviewers were all trained 
in the United Kingdom and inter-rater 
reliability tests were performed regularly 
during the period of data collection in all 
participating countries. 
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The IMAGE consortium is a  part of  the Genetic Association Information Network (GAIN), a public-
private partnership of FNIH (Foundation for the National Institutes of Health, Inc.) that currently involves 
NIH, Pfizer, Affymetrix, Perlegen Sciences, Abbott, and the Eli and Edythe Broad Institute (of MIT and 
Harvard University) (http://www.fnih.org). A total of 958 affected proband-parent trios from IMAGE 
were initially selected for a GWAS. Genotyping was conducted at Perlegen Sciences using their 
genotyping platform, which comprises approximately 600,000 tagging single –nucleotide polymorphisms 
(SNPs) designed to be in high linkage disequilibrium with untyped SNPs for the HapMap populations. 
Quality control of the genotype data was performed by NCBI (The National Center for Biotechnology 
Information) using the GAIN QA/QC Software Package (version 0.7.4) developed by Gonçalo Abecasis 
and Shyam Gopalakrishnan at the University of Michigan. Details of the genotyping and data cleaning 
process for the ADHD GAIN study (Study Accession, phs000016.v1.p1) have been reported elsewhere 
(Neale et al. 2008). Briefly, we selected only SNPs with minor allele frequency (MAF) ≥ 5% and Hardy–
Weinberg equilibrium (HWE) P ≥ 1.00E-06. Genotypes causing Mendelian inconsistencies were 
identified by PLINK (http://pngu.mgh.harvard.edu/purcell/plink/) and removed (Purcell et al. 2007). 
PLINK is the name of a tool that offers a powerful, user-friendly performance of many common analyses 
with whole-genome data. 
We additionally removed SNPs that failed the quality control metrics for the other two GAIN Perlegen 
studies (for Major Depression Disorder (dbGAP Study Accession phs000020.v1.p1) and Psoriasis 
(dbGAP Study Accession phs000019.v1.p1)). With this filtering, 384,401 autosomal SNPs were retained 
in the final dataset. To increase coverage in the targeted genomic areas, we used the imputation approach 
implemented in PLINK (v1.04), which imputes genotypes of SNPs that are not directly genotyped in the 
dataset, but that are present on a reference panel. The PLINK algorithm is an extension of multimarker 
tagging. The reference panel used consisted of 2,543,285 polymorphic autosomal SNPs genotyped on the 
60 HapMap CEU founders which are publicly available for download from the HapMap website 
(Caucasian sample included in the HapMap r23 build, http://www.hapmap.org). A threshold of 0.95 
Met opmaak: Lettertype: 12 pt, Niet
Cursief
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confidence level was set for a hard genotype call to be included in association testing. Most likely 
genotypes for imputed SNPs were then used in association analyses. 
 
Statistical Analysis 
For statistical analysis, the PACS motor answers “no motor problems” and “possible motor problems” 
were combined into an “unaffected” category creating a binary outcome variable. We chose this rather 
strict way of analysis because standard deviations of motor scores were overlapping for the groups “no 
motor problems” and “possible motor problems” whilst the definitely affected category formed a truly 
different group (not shown). An ANOVA was performed with the binary PACS trait as independent and 
DCD-Q total scores as dependent variables to validate the motor question in a sample of 313 Dutch 
IMAGE participants for whom scores from both PACS and DCD-Q were available. A total of 296 
children out of these 313 had complete data for all covariates and were included in the analysis. 
Association analysis of 890 ADHD probands with motor data was conducted using the logistic procedure 
implemented in PLINK with the motor variable from PACS as a binary outcome. The analysis was 
adjusted for age, gender, Conners’ hyperactive/impulsive score, Conners’ inattentive score and the 
country in which the motor variable was measured.  
SNPs showing association P-values < 10.00E-05 in the GWAS were tested for their association with the 
four subscales (fine and gross motor scores, general coordination and control during movement) of the 
DCD-Q. This association analysis was conducted in 313 Dutch ADHD probands using the linear 
procedure implemented in PLINK. Each DCD-Q variable was a continuous outcome and the models were 
adjusted for age, gender, Conners’ hyperactive/impulsive score and Conners’ inattentive score. In order to 
control for multiple testing, an extra permutation step was added to the linear test by applying the max(T) 
permutation approach implemented in PLINK. A total of 10000 permutations were done for the subset of 
SNPs passing the P-value threshold to determine empirical (EMP) P-values for association. 
 
Bioinformatics analysis 
Verwijderd: Due to missing covariate 
data we analyzed 296 of these 313 children. 
Met opmaak: Lettertype: 12 pt, Niet
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In order to detect significantly enriched gene functional groups in 97 genes from the GWAS containing at 
least one SNP showing association with the PACS motor variable at P < 10.00E-04, we performed 
functional analyses using the Ingenuity Pathway Analysis software package (http://www.ingenuity.com). 
In the presentation of the results of these analyses, only gene categories with significant enrichment (i.e. 
False Discovery Rate corrected P < 0.05) and containing more than one gene were taken into account. 
The Ingenuity software package uses information from the published literature as well as many other 
sources, including gene expression and GO (gene ontology) terms databases, to assign genes to different 
groups and categories of functionally related genes. Broadly speaking, ‘Ingenuity genes’ are assigned to 
one or more of three groups of gene functional categories, i.e. ‘diseases and disorders’, ‘canonical 
pathways’ and ‘physiological systems development and function’. Each of these categories can be further 
divided into many subcategories (http://www.ingenuity.com). In this study, we specifically looked at the 
5 top-ranked ‘diseases and disorders’ gene functional categories and subsequently at the 5 top-ranked 
subcategories within the ‘neurological disease’ gene functional category. In addition, we looked at the top 
5 ‘canonical pathways’ and ‘physiological systems development and function’ gene functional categories.  
The NCBI databases (http://www.ncbi.nlm.nih.gov/sites/entrez/), the UCSC Genome Browser 
(http://genome.ucsc.edu), the HapMap project website (http://www.hapmap.org) and the website of the 
Sullivan Lab Evidence Project (http://slep.unc.edu) were used to find information on gene function and 
prior association of the genes of interest with psychiatric disorders. 
 
 
 
 
Results 
  
A sample of 890 children with ADHD combined type had complete data for the PACS interview 
including information on motor development and had valid genotyping data. The mean age of the sample 
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was 10.8 years (SD 2.8, age range 5 to 17 years) and 85.3% was male (see Table 1). A total of 199 
children (22.4%) were reported by their parents to have definite motor problems, and 225 (25.3%) were 
noted with possible motor problems. Scores for the DCD-Q were available for 313 Dutch IMAGE 
individuals (Table 1). Groups based on PACS motor scores showed a significant difference in DCD-Q 
motor scores, both in total score (F=36.89, P < 0.001) and in scores of the subscales (motor control in 
motion F=16.45, P < 0.001, fine motor control/handwriting F=13.93, P < 0.001, gross motor 
control/planning F=14.27, P < 0.001, general coordination F=8.40, P = 0.004). Of those children showing 
definite motor problems in PACS (n=92), 66 children (72%) also scored clinically on the DCD-Q total 
score (in the lowest 15th percentile of the normal population), see Table 2. The Spearman correlation 
between the scores on the motor coordination item of the PACS and the DCD-Q total score was -0.340 (P 
< 0.001).  
 
A total of 580 SNPs showed association with the PACS motor scores at P-values < 10.00E-04. The most 
significant association was observed for a SNP in an intron of SLC7A2 (P-value = 1.90E-06), 58 
additional SNPs showed association P-values < 10.00E-05 (Table 3). Of the 580 PACS-associated SNPs, 
174 were located in 97 genes (Supplementary Table 1). Bioinformatics analysis using the Ingenuity 
pathway program revealed that 45 of the 97 primary genes from the GWAS fell into the ‘neurological 
disease’ gene category (P = 6.57E-06; Table 4). These 45 genes were most significantly enriched in five 
subcategories of the ‘neurological disease’ category: ‘neurodegenerative disorder’ (22/97 genes; P = 
6.57E-06), ‘progressive motor neuropathy’ (23/97 genes; P = 2.10E-05), ‘amyotrophic lateral sclerosis’ 
(15/97 genes; P = 5.42E-05) and two psychiatric disorders, ‘bipolar affective disorder’ (19/97 genes; P = 
7.40E-04) and ‘schizophrenia’ (10/97 genes; P = 1.01E-02) (Table 5).  
Other gene functional subcategories found significantly enriched in the 97 top candidate genes were 
‘synaptic long term depression’ (6/97 genes; P = 1.54E-02) and ‘nervous system development and 
function’  (6/97 genes; P = 4.00E-02) (Table 6). 
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Further characterization of the 59 SNPs showing P-values < 10.00E-05 for association with the PACS 
motor score using a more elaborate measure of motor coordination, the DCD-Q, revealed 15 SNPs with 
P-values < 0.05 that were associated with different subscales (Table 3). Permutation testing showed that 
two SNPs had significant empirical P-values: rs11002745 for the gross motor scale (EMP P = 0.045) and 
rs2839083 for the fine motor scale (EMP P = 0.014). While most DCD-Q subscale-associated SNPs 
influenced only one of the subscales, one SNP near the COL6A1 gene influenced control during 
movement and fine motor control (Table 3). 
 
Of the 59 SNPs (Table 3), 17 were located within exonic, intronic or untranslated regions of nine different 
genes (see Supplementary Table 2 for information regarding gene function and published association with 
psychiatric disorders). A comprehensive search of the literature and databases indicated that eight of the 
nine encoded proteins function in a signalling network that operates in functional processes linked to 
neurite outgrowth, as recently also implicated in ADHD etiology (Poelmans et al., submitted). 
Interestingly, the same eight proteins are expressed in skeletal muscle, where they play important roles in 
basic muscle function (see Figure 1 and Supplementary File 1). 
 
Discussion 
 
This report describes the first GWAS of motor coordination problems. Although none of the associations 
reached genome-wide significance, i.e. a P-value ≤ 7.20E-08 (Dudbridge and Gusnanto 2008), the 
findings are intriguing and can give input to further hypothesis-driven follow-up studies.   
The finding that eight of the nine proteins encoded by the top-ranked findings from our GWAS (with P-
values < 10.00E-05) function in a signalling network operating in neurite outgrowth is in line with 
another recent study of our group finding that 44 of the 85 top-ranked ADHD candidate genes from the 
five reported GWAS for ADHD are involved in neurite outgrowth (Poelmans et al., submitted).  
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The finding that the same eight genes/proteins are also involved in muscle function is particularly 
intriguing. Motor coordination problems should not be viewed merely as a neuronal problem. They are 
related to the whole range of functional processes located in the cerebrum, cerebellum, motor neurons, 
neuromuscular junctions, muscle sensors and muscle cells. Motor skills are also the result of many 
different processes such as perceptual, feedback and learning processes, motor preparation and movement 
execution processes. These processes rely on the visual system, memory, attention, the balance system, 
the kinaesthetic system (“feeling one's body”) and the motor effector system (Raynor 2001; Schoemaker 
et al. 2001; Visser 2003; Geuze 2005; Smits-Engelsman et al. 2008). Any defect in one of these processes 
or systems may lead to motor coordination problems. Thus, our findings of motor coordination associated 
genes that are expressed in both nerve tissue and muscle may provide a rationale for further studies of 
basic muscle function in DCD.  
The bioinformatics analysis revealed that 45 of the 97 primary genes from the GWAS (P < 10.00E-04) 
fell into the ‘neurological disease’ functional gene category. Among the most significantly enriched 
subcategories were ‘progressive motor neuropathy’ and ‘amyotrophic lateral sclerosis’. Interestingly, a 
relationship between ADHD and Amyotrophic Lateral Sclerosis (ALS), an adult onset, polygenic disease 
of motor neuron degeneration (Ravits and La Spada 2009; Valdmanis et al. 2009; Van der Graaff et al. 
2009), has recently been hypothesized (Lule et al. 2008). The authors argue that many patients developing 
ALS fulfilled clinical characteristics of ADHD in earlier years of their lives. At the neurobiological level, 
there is evidence for hyperactivity of the glutamatergic system and a dopaminergic hypoactivity in both 
ADHD and ALS (Lule et al. 2008). Therefore, Lule et al. hypothesized that clinical features of ADHD 
may be a risk factor for the development of ALS, and our finding from the Ingenuity pathway analysis 
may provide further input to this hypothesis.  
However, whether children with ADHD and motor coordination problems might be at a particularly high 
risk for developing ALS in later life needs to be explored in further studies. 
The Ingenuity analysis further showed that the functional categories ‘synaptic long term depression’ and 
‘nervous system development and function’ were significantly enriched in the 97 top-ranked genes. It has 
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been shown that long-term depression of neurotransmission leads to physical changes in neuronal circuits 
(Johnston 2009). Moreover, it is this neuronal plasticity that allows reorganization of neuronal networks 
and learning. Given that motor learning disturbances such as difficulties in mastering new motor skills 
like swimming and riding a bicycle are a hallmark of motor coordination problems in children (Sugden 
2007),  our results are particularly interesting.  
In addition to the enrichment of motor neuropathy and ALS genes in the top-ranked findings from the 
GWAS, more evidence of genes involved in motor dysfunction is present in our data: COL6A1 codes for 
a collagen found in most connective tissues and important in organizing extracellular matrix components. 
Mutations in this gene are known to cause motor problems in Bethlem myopathy and Ullrich scleroatonic 
muscular dystrophy (Lampe and Bushby 2005; Baker et al. 2007; Nadeau et al. 2009). Several patients 
with autosomal recessive myosclerosis have also shown mutations in this gene (Merlini et al. 2008). 
Another interesting finding was the association of motor coordination problems with the MAP2K5 gene, a 
member of the mitogen-activated protein kinase family. Previously, this gene has been consistently 
associated with Restless Legs Syndrome (RLS) in GWAS (Winkelmann 2008; Kemlink et al. 2009; 
Trenkwalder et al. 2009). RLS is a neurologic disorder characterized by uncomfortable and unpleasant 
sensations in the legs that occur at rest, usually at night, and induce an irresistible desire to move the legs. 
A large population-based study has recently reported a prevalence of RLS of 2% in children and 
adolescents without ADHD (Picchietti and Picchietti 2008), whereas up to 44% of children with ADHD 
have symptoms of RLS (Cortese et al. 2005). Several authors have suggested that RLS and ADHD share 
common risk genes (Schimmelmann et al. 2009; Reif 2010). In this light, our finding of the MAP2K5 
gene being associated with motor coordination problems in children with ADHD is interesting.  
A recent finding also links the CHD6 gene, one of our other main findings, to motor behaviour, as a 
deletion of exon 12 of this gene leads to motor coordination problems in a mouse model (Lathrop et al. 
2010).  
The association analysis of the candidate genes with the DCD-Q subscales (i.e. fine and gross motor 
scores, general coordination and control during movement) provided insight into the sources of motor 
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impairment at an additional level. In that way, we were able to characterize the movement ‘domain’ that 
was influenced by the genetic variants identified. For 15 out of 59 tested SNPs, we found DCD-Q 
associations with P-values <0.05. The intergenic SNP rs11002745, located on chromosome 10, and SNP 
rs2839083, located 18.7 kb downstream of the COL6A1 gene on chromosome 21, survived multiple 
testing correction. The former SNP showed association with gross motor problems, the latter SNP was 
associated with fine motor problems as well as control during movement. As children with motor 
coordination problems show a heterogeneous phenotype with some of them being mainly disturbed in 
fine and others in gross motor performance (Polatajko and Cantin 2005; Green et al. 2008), it is not 
surprising that we find these different associations.  
Since this is the first GWAS of motor coordination problems, it is only a first step in identifying genetic 
factors contributing to these problems. Our study was also underpowered, even though we collected a 
large sample of children with motor coordination problems in which we tried to increase genetic 
homogeneity of the motor coordination problem by focusing on children with ADHD only.  
Another potential limitation of our study is the sparseness of the motor assessment in the international 
IMAGE sample, with only one question pertaining to motor problems in the PACS. Recognizing this, we 
chose a conservative approach in pooling the unaffected and possibly affected individuals together as 
non-affected, which has probably reduced the power of our study. Still, the affected group might show 
different types of motor problems, as is also suggested by the fact that 28% of people scoring positive for 
motor problems on PACS scored negative on the more extensive DCD-Q.  
 
The overall correlation of the PACS item with the total DCD-Q score was thus modest, which on the one 
hand supports the validity of the PACS item but on the other hand also indicates that this item and the 
DCD-Q measure somewhat different movement problems. In addition, it would have been preferable to 
use objective motor tests in our study. However, these tests are time-consuming, expensive and less 
compatible with testing large samples of children, as was done in our study. Nevertheless, the substantial 
                 
 
 
17 
 
evidence of the involvement of the genes from the top-ranks of this GWAS in other movement disorders 
strongly validates our approach. 
Taken together, our findings raise the intriguing possibility that motor coordination problems are 
associated with genes expressed in both nerve tissue and skeletal muscle. Replication studies in 
independent samples are necessary to confirm or refute the presented results. However, despite extensive 
efforts from our side to find such samples, at the current time, they do not seem to be available in the 
international research community.  
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Table 1. Descriptives of the study population measured with the PACS (n=890) and the DCD-Q (n=313) 
  
Sample of children with ADHD and PACS (n) 890 
Age (years mean (SD)) 10.8 (2.8) 
Gender (% male) 85.3 
Conners score (mean (SD)) hyperactivity/impulsivity 78.8 (10.3) 
Conners score (mean (SD)) inattentiveness  71.3 (9.0) 
Sample of children with DCD-Q scores (n) 313 
DCD-Q total score (SD) 53.7 (9.5) 
  DCD-Q control during movement (SD) 19.9 (5.4) 
  DCD-Q fine motor (SD) 11.2 (3.2) 
  DCD-Q gross motor (SD) 13.1 (2.9) 
  DCD-Q general coordination (SD) 9.6 (2.8) 
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Table 2. Comparison PACS and DCD-Q motor affection in 296 children participating in the Dutch part of IMAGE 
 
N children 
 
DCD-Q unaffected  
 
DCD-Q affected 
 
PACS motor-unaffected 
 
121 
 
83 
 
PACS motor-affected 
 
26 
 
66 
 
 
  
 
Verwijderd: un
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Table 3. Top single SNPs with P < 10.00E-05 from the GWAS for motor coordination  problems in children with ADHD and DCD-Q results. The 24 
SNPs showing a significant P-value for one of the DCD-Q results are indicated in bold.  
 
chr SNP Position 
(base pair) 
 
P-values  position ~ gene gene P-values 
DCD-Q 
control 
P-values 
DCD-Q 
fine motor 
P-values 
DCD-Q  
gross 
motor 
P-values 
DCD-Q 
general 
coord 
1 rs6687919 111198699 9.29E-05 < 20 kb upstream CD53 7.24E-01 9.47E-01 3.29E-02 6.02E-01 
1 rs6687898 111198839 9.29E-05 < 20 kb upstream CD53 7.24E-01 9.47E-01 3.29E-02 6.02E-01 
1 rs6690536 111198974 9.29E-05 < 20 kb upstream CD53 7.24E-01 9.47E-01 3.30E-02 6.02E-01 
2 rs17762507 85247495 1.98E-05 intron TCF7L1 1.09E-01 5.72E-02 4.66E-01 4.44E-01 
2 rs6733332 231346384 8.99E-05 intron CAB39 9.42E-01 5.41E-01 9.56E-01 5.40E-01 
3 rs6550788 23734941 3.43E-05 < 100 kb upstream UBE2E1 3.78E-01 2.52E-01 2.22E-01 2.29E-01 
4 rs12643829 16989235 5.26E-05 < 100 kb upstream CLRN2 3.81E-01 3.21E-01 5.92E-01 4.20E-01 
4 rs7442317 29512150 3.62E-06 intergenic - 3.83E-01 7.65E-01 7.69E-01 6.94E-01 
4 rs16882428 29512172 3.62E-06 intergenic - 3.83E-01 7.65E-01 7.69E-01 6.94E-01 
4 rs7690092 29516307 3.62E-06 intergenic - 3.83E-01 7.65E-01 7.69E-01 6.94E-01 
4 rs953797 29523996 3.62E-06 intergenic - 3.83E-01 7.65E-01 7.69E-01 6.94E-01 
4 rs10023178 29526536 3.62E-06 intergenic - 3.83E-01 7.65E-01 7.69E-01 6.94E-01 
4 rs1503966 29538600 1.93E-05 intergenic - 3.81E-01 1.84E-01 7.49E-01 7.42E-01 
4 rs6837917 29558689 7.87E-05 intergenic - 8.80E-01 1.40E-01 1.07E-01 9.44E-01 
4 rs12511112 85895123 9.16E-05 intron WDFY3 2.28E-01 1.09E-01 7.59E-02 8.23E-01 
4 rs3098928 85898827 9.16E-05 intron WDFY3 2.28E-01 1.09E-01 7.59E-02 8.23E-01 
4 rs6858666 85948960 9.16E-05 intron WDFY3 2.28E-01 1.09E-01 7.59E-02 8.23E-01 
4 rs6531775 85949938 9.16E-05 intron WDFY3 2.28E-01 1.09E-01 7.59E-02 8.23E-01 
4 rs6835046 85973968 9.16E-05 intron WDFY3 2.28E-01 1.09E-01 7.59E-02 8.23E-01 
4 rs2046402 85981409 9.16E-05 intron WDFY3 2.28E-01 1.09E-01 7.60E-02 8.23E-01 
4 rs2869216 85984565 9.16E-05 intron WDFY3 2.28E-01 1.09E-01 7.60E-02 8.23E-01 
4 rs11097028 86088807 5.61E-05 intron WDFY3 8.57E-01 3.08E-01 4.72E-03 9.10E-01 
4 rs6820517 86089649 5.61E-05 intron WDFY3 8.57E-01 3.08E-01 4.72E-03 9.10E-01 
4 rs12502559 86094664 5.61E-05 intron WDFY3 8.57E-01 3.08E-01 4.72E-03 9.10E-01 
4 rs10012888 182392020 7.21E-05 intergenic - 5.09E-02 2.98E-01 3.74E-01 4.94E-01 
5 rs10462643 7720153 8.40E-05 intron ADCY2 4.90E-01 1.16E-01 3.45E-01 1.92E-02 
5 rs747243 7736784 8.40E-05 intron ADCY2 4.90E-01 1.16E-01 3.45E-01 1.92E-02 
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5 rs1366414 7743296 8.40E-05 intron ADCY2 4.90E-01 1.16E-01 3.45E-01 1.92E-02 
5 rs6895553 114849566 8.63E-05 <30 kb downstream FEM1C 9.30E-01 2.27E-02 2.21E-01 9.16E-01 
6 rs4413658 2313641 3.37E-05 100 kb upstream  GMDS 3.19E-02 2.79E-01 4.69E-01 2.58E-01 
6 rs7449538 2314638 3.37E-05 100 kb upstream GMDS 3.20E-02 2.79E-01 4.69E-01 2.58E-01 
6 rs9503158 2315074 3.37E-05 100 kb upstream GMDS 3.20E-02 2.79E-01 4.69E-01 2.58E-01 
6 rs1883587 2319820 3.37E-05 100 kb upstream GMDS 3.20E-02 2.79E-01 4.69E-01 2.58E-01 
6 rs1883588 2319887 3.37E-05 100 kb upstream GMDS 3.19E-02 2.79E-01 4.69E-01 2.58E-01 
6 rs4507577 19564453 3.38E-05 intergenic - 2.76E-01 5.78E-01 3.46E-01 4.19E-01 
7 rs2075000 150764725 4.99E-05 intron CRYGN 2.90E-02 1.55E-01 3.32E-01 5.02E-01 
7 rs12534366 150769315 5.27E-05 intron CRYGN 3.43E-02 1.95E-01 2.53E-01 5.62E-01 
7 rs11766792 152862485 1.20E-05 intergenic - 9.08E-01 2.16E-01 9.24E-02 4.33E-03 
8 rs7819754 16125110 6.75E-05 < 50 kb upstream  MSR1 3.06E-01 3.96E-01 3.12E-01 6.64E-01 
8 rs10090333 16131941 6.37E-05 < 50 kb upstream  MSR1 1.07E-01 3.21E-01 3.94E-01 2.39E-01 
8 rs2248010 17460770 1.90E-06 intron SLC7A2 7.00E-02 6.55E-01 2.71E-01 4.29E-01 
9 rs13283363 34832242 2.66E-05 < 10 kb upstream  C9ORF144 7.86E-01 1.29E-01 7.67E-01 2.48E-01 
9 rs12726 35394840 9.45E-05 exon UNC13B 2.78E-01 1.42E-01 2.37E-01 8.92E-01 
10 rs11002745 80370924 1.98E-05 intergenic - 6.53E-01 4.89E-01 4.49E-03 1.86E-01 
10 rs6480913 80379260 7.26E-05 intergenic - 5.13E-01 4.87E-01 4.93E-02 3.14E-01 
10 rs7092666 125267555 1.01E-05 intergenic - 1.16E-01 4.38E-01 2.49E-01 7.95E-01 
11 rs1393878 13869322 7.27E-05 <100 kb upstream  SPON1 2.03E-01 3.23E-01 8.02E-01 8.25E-01 
15 rs16951001 65641295 6.78E-05 intron MAP2K5 9.61E-02 9.53E-01 9.42E-01 3.01E-01 
15 rs11638507 65661099 6.72E-05 intron MAP2K5 1.42E-01 9.96E-01 7.65E-01 3.24E-01 
15 rs17241403 65662816 6.72E-05 intron MAP2K5 1.42E-01 9.96E-01 7.65E-01 3.24E-01 
15 rs1878699 65687937 6.72E-05 intron MAP2K5 1.42E-01 9.96E-01 7.65E-01 3.24E-01 
15 rs17811219 85564053 2.35E-05 intergenic  6.14E-01 2.01E-01 3.40E-01 3.06E-01 
17 rs14003 17045439 5.37E-05 exon PLD6 5.08E-02 2.59E-01 7.66E-01 6.93E-01 
17 rs9894565 17047909 6.74E-05 exon PLD6 3.13E-02 1.43E-01 4.20E-01 9.84E-01 
17 rs1736217 17068881 6.74E-05 intron FLCN 3.13E-02 1.43E-01 4.20E-01 9.84E-01 
18 rs4800802 23179814 6.49E-05 intergenic 
- 8.48E-01 7.81E-01 4.72E-01 6.69E-01 
20 rs4812506 39487624 1.80E-05 intron CHD6 3.25E-01 2.06E-01 9.95E-01 1.51E-01 
20 rs761024 39490051 1.98E-05 intron CHD6 3.26E-01 2.30E-01 8.60E-01 2.02E-01 
21 rs2839083 46268084 8.87E-05 < 20 kb downstream COL6A1 2.39E-03 4.79E-04 3.00E-01 5.64E-01 
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Table 4. Top 5 ‘diseases and disorders’ gene functional categories that are significantly enriched in the top 97 ADHD candidate genes from the GWAS for motor 
coordination problems in children with ADHD (see Supplementary Table 1) using Ingenuity pathway analysis. The 6 genes containing at least one SNP that 
yielded a P- value < 10.00E-05 (see Table 3) are indicated in bold.  
 
Category 
 
Genes Significance a Adjusted significance b 
Cardiovascular disease 
(35/97 genes) 
ACPP, AKAP6, BMPER, BRUNOL4, C3ORF31, CDH13, CNTN3, CNTNAP2, 
DAB1, ENPP1, EPB41L4A, FAM130A2, GMDS, MAML2, MAP2K5, MEF2B, 
MICAL2, NR3C1, PKD1L2, PKP2, PNPLA7, RBMS3, RELN, RYR2, RYR3, 
SASH1, SCAPER, SLC7A2, SORCS3, SOX5, SPAG16, THRB, TMEM132D, 
TRIO, UNC13B 
5.96E-09 
 
2.68E-06 
 
Neurological disease 
(45/97 genes) 
ACPP, ADCY2, ANXA6, ATP6V0A4, BRUNOL4, CAB39, CDH13, CNTNAP2, 
DAB1, GAD2, GMDS, GPR88, GRM4, MAML2, MICAL2, MLLT3, NF1, 
NGFB, NR3C1, PIP4K2A, PKD1L2, PLA2G4A, PTPRG, RAG1, RBMS2, 
RBMS3, RELN, RYR2, RYR3, SCN11A, SLC1A3, SLC35C1, SLC6A1, SLC7A2, 
SNX27, SORCS3, SOX5, SPAG16, TCF7L1, THRB, TMEM132D, TRIO, 
TRIP12, TUFT1, WDFY3 
3.84E-08 
 
6.57E-06 
 
Endocrine system disorders 
(31/97 genes) 
ADCY2, AKAP6, CDH13, CNTN3, CNTNAP2, DAB1, ENPP1, EPB41L4A, 
FARP2, FLCN, GMDS, MAML2, ME3, MICAL2, NR3C1, PIP4K2A, PTPRG, 
RBMS3, RYR2, RYR3, SASH1, SCN11A, SLC6A1, SORCS3, SOX5, SPAG16, 
TCF7L1, THRB, TMEM132D, TRIO, WDFY3 
5.36E-06 
 
2.19E-04 
 
Gastrointestinal disease 
(21/97 genes) 
ACPP, AKAP6, CDH13, CNTNAP2, DAB1, EPB41L4A, GMDS, MAML2, 
MAP2K5, MICAL2, NR3C1, PKD1L2, PTPRG, RBMS3, RYR2, SLC6A1, 
SORCS3, SOX5, TMEM132D, TUFT1, WDFY3 
1.74E-05 
 
5.60E-04 
 
Inflammatory disease 
(32/97 genes) 
ACPP, ADCY2, AKAP6, BRUNOL4, CDH13, CNTNAP2, DAB1, ELMOD2, 
ENPP1, EPB41L4A, FARP2, GAD2, GMDS, MAML2, MAP2K5, MICAL2, 
MLLT3, NGFB, NR3C1, PKD1L2, PTPRG, RBMS3, RYR2, RYR3, SCN11A, 
SLC1A3, SLC6A1, SORCS3, SOX5, SPAG16, TMEM132D, WDFY3 
 
1.74E-05 
 
5.60E-04 
 
 
Abbreviations : GWAS, genome-wide association study, ADHD, attention-deficit hyperactivity disorder, SNP, single nucleotide polymorphism 
 a 
 Single test P-values 
 b  Multiple test-corrected P-values using the Benjamini-Hochberg correction  
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Table 5. Top 5 gene functional subcategories of the ‘neurological disease’ category that are significantly enriched in the top 97 candidate genes from the GWAS 
for motor coordination problems in children with ADHD using Ingenuity pathway analysis. The 4 genes containing at least one SNP that yielded a P value < 
10.00E-05 are indicated in bold.  
 
Subcategory 
 
Genes Significance a Adjusted significance b 
Neurodegenerative disorder 
(22/97 genes) 
ADCY2, ATP6V0A4, CDH13, CNTNAP2, DAB1, GAD2, GMDS, GRM4, 
MICAL2, NR3C1, PLA2G4A, RELN, RYR2, RYR3, SCN11A, SLC1A3, SLC6A1, 
SLC7A2, SORCS3, TMEM132D, TRIO, TUFT1 
 
3.84E-08 6.57E-06 
Progressive motor neuropathy 
(23/97 genes) 
ADCY2, BRUNOL4, CDH13, DAB1, GAD2, GMDS, MAML2, MLLT3, NF1, 
NR3C1, PKD1L2, RBMS2, SCN11A, SLC1A3, SLC35C1, SLC6A1, SOX5, 
SPAG16, THRB, TMEM132D, TRIP12, TUFT1, WDFY3 
 
3.73E-07 2.10E-05 
Amyotrophic lateral sclerosis 
(15/97 genes) 
ADCY2, BRUNOL4, CDH13, DAB1, GAD2, GMDS, RBMS2, SCN11A, 
SLC1A3, SLC35C1, SLC6A1, SPAG16, TMEM132D, TUFT1, WDFY3 
 
1.09E-06 5.42E-05 
Bipolar affective disorder 
(19/97 genes) 
ACPP, CDH13, CNTNAP2, DAB1, GAD2, GMDS, GRM4, NR3C1, PIP4K2A, 
PTPRG, RBMS3, RELN, SCN11A, SLC1A3, SNX27, SOX5, TCF7L1, THRB, 
TMEM132D 
 
2.64E-05 7.40E-04 
Schizophrenia 
(10/97 genes) 
CNTNAP2, DAB1, GAD2, GRM4, NR3C1, PIP4K2A, PLA2G4A, RELN, 
SLC6A1, SNX27 
 
5.78E-04 1.01E-02 
     
Abbreviations : GWAS, genome-wide association study, ADHD, attention-deficit hyperactivity disorder, SNP, single nucleotide polymorphism 
 a 
 Single test P-values 
 b  Multiple test-corrected P-values using the Benjamini-Hochberg correction  
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Table 6. Top 5 ‘canonical pathways’ (1) and ‘physiological system development and function’ (2) gene functional categories that are significantly enriched in the 
top 97 candidate genes from the GWAS for motor coordination problems in children with ADHD using Ingenuity pathway analysis. The ADCY2 gene is indicated 
in bold because it contains 3 SNPs that yielded a P-value < 10.00E-05.    
 
Category 
 
Genes Significance a Adjusted significance b 
Synaptic long term depression (1) 
(6/97 genes) 
ADCY2, ADCY6, GRM4, PLA2G4A, RYR2, RYR3 1.29E-04 1.54E-02 
Behaviour (2) 
(2/97 genes) 
GAD2, NGFB 5.79E-03 4.00E-02 
Embryonic development (2) 
(3/97 genes) 
EZR, FARP2, SCN11A 5.79E-03 4.00E-02 
Hematological system development and function (2) 
(2/97 genes) 
GAD2, NGFB 5.79E-03 4.00E-02 
Nervous system development and function (2) 
(6/97 genes) 
FARP2, GAD2, GRM4, NGFB, SLC1A3, SLC6A1 5.79E-03 4.00E-02 
     
Abbreviations : GWAS, genome-wide association study, ADHD, attention-deficit hyperactivity disorder, DCD, developmental coordination disorder, SNP, 
single nucleotide polymorphism 
 a 
 Single test P-values 
 b  Multiple test-corrected P-values using the Benjamini-Hochberg correction  
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Figure legends 
 
Figure 1: Schematic representation of a gene/protein network potentially contributing to 
motor coordination problems in children with ADHD by influencing skeletal muscle cell 
(SMC) function. The eight proteins encoded by genes containing at least one SNP yielding a 
P value < 10.00E-05 in the GWAS for motor coordination problems in children with ADHD 
are indicated in yellow. The proteins that are encoded by AKAP6, MEF2B  - two genes that 
contain at least one SNP associated at P < 10.00E-04 (Supplementary Table 1) - and NOS1 - a 
gene found associated with ADHD in the GWAS by Lasky-Su et al. (Lasky-Su et al. 2008) - 
are indicated in orange. A more elaborate description of the network can be found in 
Supplementary File 1.  
 
a : cell membrane ; b : cytoplasm ; c : nucleus ; d : mitochondrion ; e : extracellular 
matrix/compartment   
